Tafamidis for Transthyretin Amyloid Cardiomyopathy Tafamidis for Transthyretin Amyloid Cardiomyopathy

A new drug for the treatment of transthyretin cardiomyopathy looks to be a game-changer; but will it benefit all TTR patients?European Heart Journal
Source: Medscape Radiology Headlines - Category: Radiology Tags: Cardiology Journal Article Source Type: news